Central Coordinating Site for the Polycystic Kidney Disease Research Core Centers (U24 Clinical Trial Not Allowed)
ID: 355998Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Cooperative Agreement

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/355998

Additional Information

http://grants.nih.gov/grants/guide/rfa-files/RFA-DK-25-015.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a funding opportunity for the establishment of a Central Coordinating Site (CCS) for the Polycystic Kidney Disease (PKD) Research Core Centers, under the announcement RFA-DK-25-015. The CCS will collaborate with four Research Translation Core Centers to enhance understanding and management of PKD, providing essential administrative support, facilitating data sharing, and promoting outreach efforts, including an annual scientific symposium. This initiative emphasizes the importance of diverse perspectives in scientific innovation and aims to optimize resources for pioneering PKD research, with approximately $1.1 million available for one award, and an annual budget of about $350,000. Interested applicants must adhere to submission guidelines via Grants.gov, with a closing date for applications set for November 14, 2024. For further inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    RFA-DK-25-015-Full-Announcement.html
    RFA-DK-25-015.html
    The National Institutes of Health (NIH) is releasing a funding opportunity for a Central Coordinating Site for the Polycystic Kidney Disease Research Core Centers, denoted as RFA-DK-25-015. This initiative aims to enhance understanding and management of polycystic kidney disease (PKD) through improved collaboration within the PKD Research Resource Consortium (PKD RRC). The successful applicant will facilitate administrative support, manage data sharing, and drive outreach efforts including an annual scientific symposium. Furthermore, a focus on diversity through the required Plan for Enhancing Diverse Perspectives (PEDP) underlines the importance of varied viewpoints in scientific innovation. Funding is approximately $1.1 million for one award, with an annual budget of about $350,000, emphasizing innovative pilot projects in PKD research. Applications are to adhere strictly to submission guidelines via Grants.gov, with a range of eligibility criteria aimed at fostering participation from diverse organizational types. The central goal is to optimize resources and data sharing to promote pioneering PKD research, ultimately broadening participation from diverse scientific backgrounds while addressing barriers to research entry.
    Similar Opportunities
    Polycystic Kidney Disease Core Centers (U54 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Polycystic Kidney Disease (PKD) Core Centers through a Notice of Funding Opportunity (NOFO) aimed at enhancing national research efforts in PKD. The initiative seeks to establish four Core Centers that will collaborate within the PKD Research Resource Consortium, focusing on developing and sharing essential research tools and resources while promoting scientific diversity and engagement among a wide range of investigators. Approximately $3.44 million in funding is anticipated for FY 2025, with applications due by November 15, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    The Chronic Pancreatitis Clinical Research Consortium (CPCRC)- Clinical Centers (CPCRC-CCs) (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Chronic Pancreatitis Clinical Research Consortium (CPCRC), inviting U01 applications for Clinical Centers to conduct research on chronic pancreatitis, diabetes, and pancreatic cancer. The initiative aims to continue the consortium's work by collecting clinical data and biospecimens to identify biomarkers for risk stratification and disease progression, ultimately enhancing understanding and treatment of these conditions. With an estimated funding of $6.5 million for the 2025 fiscal year, applications are due by October 18, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Single Source for Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) (U01 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a cooperative agreement for the establishment of the Chronic Pancreatitis Clinical Research Consortium Data Coordinating Center (CPCRC-DCC) under funding opportunity RFA-DK-25-020. The primary objective is to facilitate ongoing studies on chronic pancreatitis, diabetes, and pancreatic cancer, focusing on data management, biomarker development, and clinical trial support for both pediatric and adult populations. This initiative is crucial for advancing the understanding of chronic pancreatitis and its associations with diabetes and pancreatic cancer, with an anticipated funding amount of $6.5 million over five years. Interested applicants must submit their proposals by 5:00 PM on October 19, 2024, and can direct inquiries to grantsinfo@nih.gov for further information.
    NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), is offering a funding opportunity for high-risk multi-center clinical study implementation planning via Cooperative Agreements (U34). This initiative aims to support the early peer review of proposed clinical studies, assess study designs, and develop essential documentation, including operational manuals, focusing on diseases relevant to NIDDK's mission. The program emphasizes health equity and inclusivity, requiring a Plan for Enhancing Diverse Perspectives (PEDP) as part of the application. Interested applicants can apply for up to $225,000 per year for a maximum of two years, with the application submission period opening on September 9, 2024, and the closing date set for June 10, 2027. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.
    Silvio O. Conte Digestive Diseases Research Core Centers (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Silvio O. Conte Digestive Diseases Research Core Centers (DDRCC) program, aimed at enhancing research in digestive and liver diseases. This program seeks to foster collaboration among investigators by providing shared resources that enhance productivity and interdisciplinary research, with proposals required to focus on a central theme related to digestive or liver diseases and demonstrate an existing research base with at least $3 million in annual federal funding. The DDRCC program is critical for promoting integrative research approaches and improving health outcomes in digestive health, with a maximum funding amount of $750,000 in direct costs per year for a project period of up to five years. Applications can be submitted starting January 22, 2024, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)" aimed at supporting innovative research that addresses significant knowledge gaps within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). This initiative encourages interdisciplinary approaches to foster advancements in understanding, treating, and preventing diseases related to diabetes, digestive, and kidney disorders, with a focus on generating impactful research resources and hypothesis-generating science. Eligible applicants include a wide range of institutions such as higher education entities, nonprofits, for-profits, and various governmental agencies, with project durations extending up to five years initially and a total funding period of up to ten years. Interested parties should note that the application deadline is October 30, 2024, and are encouraged to contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01), aimed at supporting investigator-initiated, high-risk clinical trials that involve multiple clinical centers. Applicants must propose hypothesis-driven studies that focus on diseases relevant to the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), with an emphasis on enhancing diverse perspectives in research. This funding opportunity is crucial for advancing therapeutic studies that can significantly improve clinical practices and public health outcomes. Interested applicants should note that the application period opens on January 5, 2024, with a closing date of November 5, 2026, and are encouraged to consult with NIDDK staff prior to submission. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) for Cancer Center Support Grants (CCSGs) aimed at supporting NCI-designated Cancer Centers under the P30 activity code. These grants are designed to foster excellence in cancer research by integrating diverse research activities and enhancing collaboration among institutions, with eligible applicants including various educational and community organizations. The CCSGs emphasize a transdisciplinary approach to cancer research, with funding amounts of up to $1.2 million for Basic Cancer Centers and $1.4 million for Clinical Cancer Centers per year, potentially extending over five years based on merit. Interested parties can find more information and application details at the NIH website, and inquiries can be directed to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV. The application deadline is set for October 12, 2121.
    NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01), aimed at supporting high-risk observational studies related to diabetes, digestive, kidney, and metabolic diseases. Applicants must complete all planning activities prior to submission, as these cannot be included in the U01 application, and a Plan for Enhancing Diverse Perspectives (PEDP) is mandatory for consideration. This funding opportunity is crucial for advancing clinical research and addressing health disparities, particularly by encouraging collaboration with underrepresented communities. Interested applicants should note that the application deadline is February 5, 2024, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Whole Person Research and Coordination Center (Whole Person RCC) U24 (Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the establishment of the Whole Person Research and Coordination Center (Whole Person RCC) as part of the NIH Whole Person Initiative. This initiative aims to create a comprehensive conceptual map of human physiology, termed the "physiome," to enhance whole person health research through multidisciplinary collaboration and the development of an in silico model of whole person physiology. The funding opportunity, which offers up to $2.5 million for one award, has a submission deadline of November 1, 2024, with an earliest submission date of October 1, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.